Santa Ana, Calif. – September 19, 2026 -- Robinson Pharma, Inc. (RPI) has received the "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026, recognizing sustained operational performance following a $115 million infrastructure expansion.
Robinson Pharma completes $115 million facility expansion across Southern California
The contract manufacturer finalized a $75 million purchase of a 261,000-square-foot facility in Irvine near John Wayne Airport, adding to a prior $40.7 million acquisition in Santa Ana. The combined investments push Robinson Pharma's regional manufacturing footprint beyond one million square feet.
Company secures USP certification after clearing quality audits
Robinson Pharma achieved United States Pharmacopeia (USP) certification following the expansion, adding to its existing FDA, NSF GRMA, UL GMP, SQF, CCOF, and SCCI credentials.
Bausch + Lomb award recognizes supply chain reliability amid demand growth
The "Above and Beyond" Supplier Award is presented to partners demonstrating exceptional performance, agility, and dedication to consumer health. A Robinson Pharma representative said the recognition reflects the work of quality control specialists and production floor operators, and that the recent infrastructure investment and USP certification demonstrate the company's commitment to regulatory compliance and manufacturing scale.
Robinson Pharma positions the expanded footprint and certification stack to support high-volume manufacturing for dietary supplements and custom formulations amid rising global demand.